Unexplained Infertility Explained
Attain Fertility Centers and The American Fertility Association continue educational video series
Purchase, NY (PRWEB) May 17, 2011
How do you treat, let alone explain, the unexplainable? Jason Griffith, M.D. of the Houston Fertility Institute unravels the complexities of Unexplained Infertility in a short video and fact sheet produced by The American Fertility Association (http://theafa.org/), with funding from Attain Fertility® Centers, an IntegraMed Specialty and provider of the Attain® IVF Programs.
According to The AFA, 12% – 25% of all infertility related cases are considered to be unexplained or idiopathic infertility and there is still much that is not known about the causes. There may be subtle, biochemical or immune factors that don’t show up through current testing protocols that stop conception. There may also be multiple simultaneous issues that individually would not stop a woman from conceiving but when coupled together, lessen the chances of achieving successful pregnancy. As hard as it is to receive a diagnosis of unexplained infertility and as baffling and frustrating as it may be, Dr. Griffith assures viewers that unexplained does not mean untreatable.
“The first course of treatment will most likely be geared towards boosting ovulation with medication and will probably be combined with Intrauterine Insemination (IUI) or In Vitro Fertilization (IVF), based on individual considerations such as maternal age,” Dr. Griffith explains. The goal is to get the sperm closer to the egg in an attempt to have fertilization take place. As infertility treatment has continued to evolve over the past decade, outcomes have continually improved and patients are encouraged to hope for a healthy pregnancy.
With the knowledge that a diagnosis as vague sounding as Unexplained Infertility can lead to confusion, frustration and even anger it is important to create a support system and to find ways to reduce stress. From joining a support group or working with a professional counselor to working with an acupuncturist and taking a yoga class, it’s important to find ways to get support and reduce stress. And as with all fertility issues, seeking the care and guidance of a fertility specialist early is always at the top of the recommendation list.
The entire AFA video series is available on Attain Fertility’s YouTube channel.
About IntegraMed America, Inc.
IntegraMed is a leader in developing, marketing and managing specialty outpatient healthcare facilities, with a current focus on the fertility and vein care markets. IntegraMed supports its provider networks with clinical and business information systems, marketing and sales, facilities and operations management, finance and accounting, human resources, legal, risk management, quality assurance, and fertility treatment financing programs.
Attain Fertility® Centers, an IntegraMed Specialty, offers the nation’s largest fertility center network, with 14 company-managed partner centers and 26 affiliate centers, comprising over 130 locations across 34 states and the District of Columbia. Nearly one of every four IVF procedures in the U.S. is performed in an Attain Fertility Centers network practice.
Vein Clinics of America, an IntegraMed Specialty, is the leading provider of specialty vein care services in the U.S. The IntegraMed Vein Clinic network operates 44 centers across 14 states, principally in the Midwest and Southeast.
For more information about IntegraMed please visit: integramed.com for investor background, attainfertility.com for fertility, or veinclinics.com for vein care.
About The American Fertility Association
The American Fertility Association is committed to preventing infertility whenever possible and to helping people build families of choice, particularly when faced with infertility. AFA services and materials are provided free of charge to consumers and available to everyone without reservation. Contact The American Fertility Association at email@example.com, visit theafa.org or call 888.917.3777.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/5/prweb8437709.htm